Please turn JavaScript on

Healthcare Communications Network

Click on the "Follow" button below and you'll get the latest news from Healthcare Communications Network via email, mobile or you can read them on your personal news page on this site.

You can unsubscribe anytime you want easily.

You can also choose the topics or keywords that you're interested in, so you receive only what you want.

Healthcare Communications Network title: Connecting Healthcare - Healthcare Communications Network

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  3.33 / day

Message History

Legal / Ethical Complexity

Maine became the first state to achieve all three AAPA priority modernization milestones after Governor Mills signed LD 2088 on April 6. The law removes written physician agreement requirements for Maine’s 1,100+ PAs with 4,000 or more practice hours.

...

Read full story

Early Stage Research
This 2024 review consolidates AD pathophysiology, risk stratification, diagnostic modalities, and treatment progress for NP/PA practice. Peripheral biomarkers and tau-targeting strategies remain research-stage; the review reports no new approvals or guideline changes.


Read full story

Rare but High‑Risk Safety Event
A federal vehicle recall following the death of a 2‑year‑old child has drawn attention to a rare but severe pediatric injury mechanism involving powered car seats. The incident underscores how thoracic compression injuries in young children may present with minimal external findings yet lead to rapid respiratory co...


Read full story

Guideline Update
Multidisciplinary experts from the Infectious Diseases Society of America (IDSA) and the Pediatric Infectious Diseases Society (PIDS) released updated clinical practice guidelines for managing pediatric community‑acquired pneumonia complicated by parapneumonic effusion and empyema. This update represents the first installment of ...


Read full story

Early‑Stage / Preclinical Research
Researchers have demonstrated a novel use of CRISPR‑based gene editing to selectively silence an extra copy of chromosome 21 in human cells. The work offers a proof‑of‑concept approach to addressing the genetic basis of Down syndrome by targeting chromosome‑level gene activity rather than single genes.

...

Read full story